Infarct size-reducing effect of ischemic preconditioning is related to otlb-adrenoceptors but not to α1a-adrenoceptors in rabbits

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 4, 1997, Pages 437-445

  Kariya, Tatsuya ^a,b   Minatoguchi, Shinya ^a   Ohno, Tsuzuki ^a   Yamashita, Kazuya ^a   Uno, Yoshihiro ^a   Aral, Masazumi ^a   Koshiji, Masatoshi ^a   Fujiwara, Takako ^a   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY   (Japan)

^b KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

Adrenoceptorinfarct size; Adrenoceptors; Ischemic preconditioning; Rabbits 1a; 1b

Indexed keywords

2 [2 (4 HYDROXYPHENYL)ETHYLAMINOMETHYL]TETRALONE; 5 METHYLURAPIDIL; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; CHLOROETHYLCLONIDINE; PHENOXYBENZAMINE;

ALPHA ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG SELECTIVITY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CLONIDINE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; PHENOXYBENZAMINE; PIPERAZINES; QUINAZOLINES; RABBITS; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0030689695     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199710000-00006     Document Type: Article

References (48)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986:74:1124-36.
2. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation 1990;82:609-19.
3. Scott RJ, Rohmann S, Braun ER, Schaper W. Ischémie preconditioning reduces infarct size in swine myocardium. Circ Res 1990;66:1133-42.
4. Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by Al-adenosine receptors in rabbit heart. Circulation 1991;84:350-6.
5. Yellon DM, Alkhulaifi AM, Browne EE, Pugsley WB. Ischaemic preconditioning limits infarct size in the rat heart. Cardiovasc Res 1992:26:983-7.
6. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischémie preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischémie episode. Circ Res 1990;66:913-31.
7. Kida M, Fujiwara H, Ishida M, et al. Ischémie preconditioning preserves creatine phosphate and intracellular pH. Circulation 1991;84:2495-503.
8. Miyamae M, Fujiwara H, Kida M, et al. Preconditioning improves energy metabolism during reperfusion but does not attenuate myocardial stunning in porcine hearts. Circulation 1993;88:223-34.
9. Thornton JD, Liu GS, Olsson RA, Downey JM. Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 1992;85:659-65.
10. Cohen MV, Downey JM. Ischaemic preconditioning: can the protection be bottled? Lancet 1993;342:6.
11. Gross GJ, Auchampach J. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-33.
12. Tanaka M, Fujiwara H, Yamasaki K, Sasayama S. Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischaemic preconditioning in the rabbit. Cardiovasc Res 1994;28:980-6.
13. Bankwara Z, Hale SL, Kloner RA. α-Adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischémie preconditioning. Circulation 1994;90:1023-8.
14. 1-Adrenergic agonists precondition rabbit ischémie myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 1994;75:576-85.
15. Thornton JD, Daly JF, Cohen MV, Yang XM, Downey JM. Catecholamines can induce adenosine receptor-mediated protection of the myocardium but do not participate in ischémie preconditioning in the rabbit. Circ Res 1993;73:649-55.
16. 1 mechanisms [Abstract]. Circulation 1994;84(suppl 2):II-433.
17. Toombs CF, Wiltse AL, Shebuski RJ. Ischémie preconditioning fails to limit infarct size in reserpinized rabbit myocardium: implication of norepinephrine release in the preconditioning effect. Circulation 1993;88(part 1):2351-8.
18. Bugge E, Ytrehus K. Ischaemic preconditioning is protein kinase C dependent but not through stimulation of a adrenergic or adenosine receptors in the isolated rat heart. Cardiovasc Res 1995;29:401-6.
19. 1-adrenoceptor subtypes mediating inotropic effects in rat right ventricle. Br J Pharmacol 1994;111:539-46.
20. 1-adrenoceptor subtypes in rat heart. Br J Pharmacol 1994;111: 533-8.
21. 1b-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation 1995;92:2259-65.
22. 2+. Pharmacol Rev 1988;40:87-119.
23. Gross G, Hanft G, Rugevics C. 5-Methyl-urapidil discriminates between subtypes of the otj-adrenoceptor. Eur J Pharmacol 1989; 151:333-5.
24. Suzuki H. Effects of bunazosin on electrical responses of smooth muscle cells of the guinea-pig mesenteric artery and vein. Gen Pharmacol 1987;18:171-7.
25. Weiner N. Drugs that inhibit adrenergic nerves and block adrenergic receptors. In: Oilman AG, Goodman LS, Oilman A, eds. Goodman and Gilman's the pharmacological basis of therapeutics. New York: Macmillan, 1988:176-210.
26. Lomasney JW, Cotecchia S, Lefkowitz RJ, Garon MG. Molecular biology of a-adrenergic receptors: implications for receptor classification and for structure-function relationships. Biochim Biophys Acta 1991;1095:127-39.
27. Maxwel MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987;21:737-46.
28. 2+ influx. Mol Pharmacol 1989;36:166-76.
29. Hua Z, Wang XL. Alpha 1a- and alpha 1b-adrenoceptor-mediated positive chronotropic effects on isolated rat atrium. Acta Pharmacol Sin 1993;14(4):317-9.
30. Graham RM, Perez DM, Hwa J, Piascik MT. a,-Adrenergic receptor subtypes: molecular structure, function, and signaling. Circ Res 1996;78:737-49.
31. Takanashi M, Norota I, Endoh M. Potent inhibitory action of chlorethylclonidine on the positive inotropic effect and phosphoinositide hydrolysis mediated via myocardial alphapadrenoceptors in the rabbit ventricular myocardium. Naunyn-Schmiedebergs Arch Pharmacol 1991:343:669-73.
32. Shoji T. Comparison of pre- and postsynaptic ct-adrenoceptor blocking effects of E-643 in the isolated vas deferens of the rat. Jpn J Pharmacol 1981;31:361-8.
33. Piascik MT, Sparks MS, Pruitt TA. Effect of chloroethylclonidine on arterial blood pressure and heart rate in the conscious rat. J Pharmacol Exp Ther 1992;262(3):901-6.
34. Tian WN, Gupta S, Deth RC. Species differences in chloroethylclonidine antagonism at vascular alpha-1 adrenergic receptors. J Pharmacol Exp Ther 1990;253:877-83.
35. Wall TM, Sheehy R, Hartman JC. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 1994;270:681-9.
36. Li Y, Kloner RA. The cardioprotective effects of ischémie "preconditioning" are not mediated by adenosine receptors in rat hearts. Circulation 1993;87:1642-8.
37. Grover GJ, Dzwonczyk S, Sleph PG, Sargent CA. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischémie rat hearts. J Pharmacol Exp Ther 1993;265:559-64.
38. 1-adenosine receptors in rabbit heart. Circulation 1991;84:350-6.
39. ATP channels, and ischémie preconditioning in dogs. Am J Physiol 1993:264: H1327-36.
40. Schwarz ER, Mohri M, Sack S. Arras M. The role of adenosine and its ctj-receptor in ischémie preconditioning [Abstract]. Circulation 1991;84(supplH):II-191.
41. Toombs CF, Moore TL, Shebuski RJ. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide. Cardiovasc Res 1993;27:617-22.
42. Przyklenk K, Sussman MA, Simkhovich BZ, Kloner RA. Does ischémie preconditioning trigger translocation of protein kinase C in the canine model? Circulation 1995;92:1546-57.
43. Kitakaze M, Node K, Minamino T, et al. Role of activation of protein kinase C in the infarct size-limiting effect of ischémie preconditioning through activation of ecto-5′-nucleotidase. Circulation 1996;93:781-91.
44. Ytrehus K, Liu Y, Downey J. Preconditioning protects ischémie rabbit heart by protein kinase C activation. Am J Physiol 1994;266: H1145-52.
45. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995;76:73-81.
46. Houslay MD. Crosstalk: a pivotal role for protein kinase C in modulating relationships between signal transduction pathways. Eur J Biochem 1991;195:9-27.
47. Mahilo G, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischémie preconditioning in rabbit hearts. Circ Res 1995;77:611-21.
48. 1-Adrenoceptor activity regulates release of adenosine from the ischémie myocardium in dogs. Circ Res 1987;60:631-9.